EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY. Int. Res. J. Pharm. [Internet]. 2024 Nov. 15 [cited 2026 Jun. 1];15(6):35-9. Available from: https://irjponline.org/index.php/irjp/article/view/92